Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 45,600 shares at $9.07 ($414K) on 2023-12-01, disclosed to the SEC on 2023-12-05.
Open-market purchase of $414k PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |